FMP
The Gabelli Healthcare & Wellness Trust
GRX
NYSE
The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
9.85 USD
0.05 (0.508%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
25.01M
43.49M
-46.71M
1.24M
342.91k
172.81k
87.08k
43.89k
22.12k
11.15k
Revenue %
-
73.93
-207.41
-102.65
-72.35
-49.61
-49.61
-49.61
-49.61
Ebitda
24.18M
42.74M
-44.26M
3.2M
-
134.7k
67.88k
34.21k
17.24k
8.69k
Ebitda %
96.71
98.27
94.76
258.39
-
77.95
77.95
77.95
77.95
Ebit
23.98M
42.5M
-44.49M
3.2M
-
134.39k
67.73k
34.13k
17.2k
8.67k
Ebit %
95.88
97.73
95.24
258.39
-
77.77
77.77
77.77
77.77
Depreciation
206.3k
236.56k
228.49k
-
-
304.07
153.24
77.22
38.92
19.61
Depreciation %
0.82
0.54
-0.49
-
-
0.18
0.18
0.18
0.18
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
11.79k
-
50.49k
2.37k
-
44.93
22.64
11.41
5.75
2.9
Total Cash %
0.05
-
-0.11
0.19
-
0.03
0.03
0.03
0.03
Receivables
5.11M
476k
6.63M
772.25k
423.69k
58.62k
29.54k
14.89k
7.5k
3.78k
Receivables %
20.43
1.09
-14.19
62.27
123.56
33.92
33.92
33.92
33.92
Inventories
-
-
-
-
-
-
-
-
-
-
Inventories %
-
-
-
-
-
-
-
-
-
Payable
3.65M
6.23M
3.53M
31.84k
183.03k
26.71k
13.46k
6.78k
3.42k
1.72k
Payable %
14.58
14.32
-7.55
2.57
53.38
15.46
15.46
15.46
15.46
Cap Ex
-
-
-
-3
-
-0.08
-0.04
-0.02
-0.01
-0.01
Cap Ex %
-
-
-
-0
-
-0
-0
-0
-0
Weighted Average Cost Of Capital
Price
9.85
Beta
Diluted Shares Outstanding
15.96M
Costof Debt
3.92
Tax Rate
After Tax Cost Of Debt
3.92
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
0
Total Equity
0
Total Capital
0
Debt Weighting
0
Equity Weighting
0
Wacc
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
25.01M
43.49M
-46.71M
1.24M
342.91k
172.81k
87.08k
43.89k
22.12k
11.15k
Ebitda
24.18M
42.74M
-44.26M
3.2M
-
134.7k
67.88k
34.21k
17.24k
8.69k
Ebit
23.98M
42.5M
-44.49M
3.2M
-
134.39k
67.73k
34.13k
17.2k
8.67k
Tax Rate
-
-
-
-
-
-
-
-
-
-
Ebiat
23.98M
42.5M
-44.49M
3.2M
-
134.39k
67.73k
34.13k
17.2k
8.67k
Depreciation
206.3k
236.56k
228.49k
-
-
304.07
153.24
77.22
38.92
19.61
Receivables
5.11M
476k
6.63M
772.25k
423.69k
58.62k
29.54k
14.89k
7.5k
3.78k
Inventories
-
-
-
-
-
-
-
-
-
-
Payable
3.65M
6.23M
3.53M
31.84k
183.03k
26.71k
13.46k
6.78k
3.42k
1.72k
Cap Ex
-
-
-
-3
-
-0.08
-0.04
-0.02
-0.01
-0.01
Ufcf
22.72M
49.96M
-53.12M
5.56M
499.75k
343.45k
83.71k
42.18k
21.26k
10.71k
Wacc
-
-
-
-
-
Pv Ufcf
343.45k
83.71k
42.18k
21.26k
10.71k
Sum Pv Ufcf
-
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
Free Cash Flow T1
10.77k
Terminal Value
Present Terminal Value
Intrinsic Value
Enterprise Value
Net Debt
0
Equity Value
Diluted Shares Outstanding
15.96M
Equity Value Per Share
Projected DCF
-InfinityE%
